Can Statins Lower Testosterone and Cause ED? (TRT Q&As)
Timeline
Statins can slightly lower testosterone in men who produce it naturally, which could indirectly contribute to erectile dysfunction. Dr. O’Connor considers the effect relatively small and emphasizes weighing it against the cardiovascular protection statins can provide when plaque or other heart risks are present.
Long-standing readings around 140–150/90–100 require better control, and 200 mg of testosterone weekly may also be contributing through fluid retention. Dr. O’Connor discusses lowering and splitting the testosterone dose, starting with telmisartan, and potentially adding another medication for better blood pressure control rather than simply maximizing one drug.
Video Summary
This mailbag discussion focuses on blood count monitoring during testosterone therapy, particularly how hematologic markers can change over time. It emphasizes understanding why these shifts occur and how to interpret them without overreaction. Monitoring is framed as a preventive safety practice rather than a trigger for abrupt changes.
A central portion explains how trends in hematologic values provide more insight than single measurements. The episode discusses variability, contributing factors, and the importance of consistent testing conditions. Contextual interpretation is emphasized to avoid unnecessary intervention.
The closing segment integrates hematologic surveillance into long-term testosterone management. Ongoing monitoring, proportional responses, and individualized risk awareness are highlighted. Hormone therapy is positioned as requiring vigilance without reflexive escalation.
Drug Callouts
Condition Callouts
Key Takeaways
- Blood count monitoring is a routine safety component of testosterone therapy.
- Hematologic trends provide more insight than single lab values.
- Contextual interpretation helps avoid unnecessary intervention.
- Proportional responses reduce risk during long-term therapy.
- Consistent surveillance supports safer hormone management.